Aspirin mediates protection from diabetic kidney disease by inducing ferroptosis inhibition
GPX4
Pathogenesis
DOI:
10.1371/journal.pone.0279010
Publication Date:
2022-12-14T18:34:35Z
AUTHORS (5)
ABSTRACT
Diabetic kidney disease (DKD) progression can be predicted by abnormalities in the tubulointerstitial lining, and their treatment may useful for preventing disease. DKD is a progressive that contributes to renal tubular cell death, but its underlying mechanisms remain unclear. Ferroptosis novel term linked lipid hydroperoxidation, it plays an important role pathogenesis of DKD. Overexpression cyclooxygenase-2 (COX2), enzyme proximal tubule, causes cellular redox damage It remains unknown whether COX2 exacerbates accelerating ferroptosis kidneys diabetic mice. HK-2 cells cultured high glucose exhibited ferroptosis, which was inhibited inhibitors. Additionally, alterations sensors metabolism, such as glutathione peroxidase 4 (GPX4) activity, reduced (GSH) levels changes mitochondrial morphology, were observed glucose-cultured cells. mice manifested injury deranged physiological indices, mitigated ferrostatin-1 (Fer-1). Importantly, these perturbations ameliorated downregulating COX2. In addition, increased elevated daibetic kindney. To explore relevance knocked down from decreased sensitivity under conditions. RSL-3-treated cells, improved with aspirin, confirmed Furthermore, also suppressed decreasing treated retarded progression. conclusion, our results demonstrated development diabetes-related through downregulation thus retarding Our findings support renoprotective mechanism aspirin inhibits activation, identify potential target establish integral process regulated expression profiles.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (45)
CITATIONS (15)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....